International group urges prompt HIV treatment for all

"A technician shows packs of Nevirapine 200mg tablets of antiretroviral drugs on July 21 at the Sociedade Mocambicana de Medicamentos, Africa's first public factory for anti-HIV drugs. An international group of scientists on Sunday called for all adults who test positive for HIV to be treated with antiretroviral drugs right away rather than waiting for their immune systems to weaken. (AFP Photo/Benoit Marquet)" title

View the Original article

Panel Urges Expanded Use of Antiretrovirals for HIV

Dr. Oz Ambushes Nurses on a Lunch Break Previous
End to AIDS Epidemic: Is It Near?Next
James Holmes Gave No Indication of Violent Delusions

TopLeave a Reply

Do you have more information about this topic? If so, please click here to contact the editors of ABC News.

Name (required)

Mail (will not be published) (required)

Website

XHTML: You can use these tags:
View the Original article

FDA panel urges approval for Pfizer arthritis drug

"An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer. (AFP Photo/Timothy A. Clary)" title

View the Original article

US urges circumcision for soldiers to fight HIV in Africa

"Male circumcision is the best way to prevent new HIV infections in the military, the head of US anti-AIDS efforts Eric Goosby, pictured here in 2011, told a gathering of top army brass from Africa, Eastern Europe and central Asia. Studies show that circumcision can dramatically reduce HIV infections. (AFP Photo/Brendan Hoffman)" title

View the Original article

Icahn says sues Amylin, urges sale

Reuters – 1 hr 6 mins ago (Reuters) - Carl Icahn said on Monday he has sued Amylin Pharmaceuticals Inc to obtain more time to nominate a slate of directors he hopes will push the maker of diabetes drugs to put itself up for sale.

Icahn, whose 8.9 percent stake has made him the company's third-largest shareholder, has faulted Amylin for failing to acknowledge media reports that it had rejected a roughly $3.5 billion takeover bid by Bristol-Myers Squibb Co.

The lawsuit was filed in Delaware, Icahn said. A copy of the complaint was not immediately available.

Amylin shares were down 49 cents, or 2 percent, at $23.63, at midday.

(Reporting By Jonathan Stempel in New York; Editing by Richard Chang)

View the Original article